Monocyte-derived Dendritic Cells in Chronic Lymphocytic Leukemia

References

• Dighiero, G., Travade, P., Chevret, S., Fenaux, P., Chastang, C. and Binet, J.L. (1991) "B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL", Blood 78, 1901–1914.
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio, F. and Hamblin, T.J. (1999) "B-cell chronic lymphocytic leukemia: a bird of a different feather", J. Clin. OncoL 17, 399–408.
   PubMed Web of Science ®Google Scholar
• Kipps, T.J. (2001) "Chronic Lymphocytic leukemia and related diseases", In: Beutler, E., Lichtman, MA., Coller, B.S., Kippts, T.J. and Seligsohn, U., eds, William's Hematology, 6th Ed. (McGrawHill, New York, NY), pp. 1163–1194.
   Google Scholar
• Ternynck, T., Dighiero, G., Follezou, J. and Binet, J.L. (1974) "Comparison of normal and CLL lymphocyte surface Ig determinants using peroxidase-labeled antibodies. I. Detection and quantitation of light chain determinants", Blood 43, 789–795.
   PubMed Web of Science ®Google Scholar
• Matutes, E., Owusu-Ankomah, K., Morilla, R., Garcia Marco, J., Houlihan, A., Que, T.H. and Catovsky, D. (1994) "The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL", Leukemia 8, 1640–1645.
   PubMed Web of Science ®Google Scholar
• Zomas, A.P., Matutes, E., Morilla, R., Owusu-Ankomah, K., Seon, B.K. and Catovsky, D. (1996) "Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b)", Leukemia 10, 1966–1970.
   PubMed Web of Science ®Google Scholar
• Rawstron, AC., Kennedy, B., Evans, P.A., Davies, FE., Richards, S.J., Haynes, A.P., Russell, N.H., Hale, G., Morgan, G.J., Jack, A.S. and Hillmen, P. (2001) "Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy", Blood 98, 29–35.
   PubMed Web of Science ®Google Scholar
• Payelle-Brogard, B., Magnac, C., Alcover, A., Roux, P. and Dighiero, G. (2002) "Defective assembly of the B-cell receptor chains accounts for its low expression in B-chronic lymphocytic leukaemia", Br. J. HaematoL 118, 976–985.
   PubMed Web of Science ®Google Scholar
• Maloum, K., Sutton, L., Baudet, S., Laurent, C., Bonnemye, P., Magnac, C. and Merle-Beral, H. (2002) "Novel flow cytometric analysis based on BCD5+ subpopulations for the evaluation of minimal residual disease in CLL", Br J. Haematol. 119, 970–975.
   PubMed Web of Science ®Google Scholar
• Dighiero, G., Maloum, K., Desablens, B., Cazin, B., Navarro, M., Leblay, R., Leporrier, M., Jaubert, J., Lepeu, G., Dreyfus, B., Binet, J.L. and Travade, P. (1998) "Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia", N. EngL J. Med. 338, 1506–1514.
   PubMed Web of Science ®Google Scholar
• Dighiero, G. and Binet, J.L. (2000) "When and How to Treat Chronic Lymphocytic Leukemia", N. Engl. J. Med. 343, 1799–1802, Record as supplied by publisher.
   Google Scholar
• Rai, KR., Sawitsky, A., Cronldte, E.P., Chanana, A.D., Levy, RN. and Pasternack, B.S. (1975) "Clinical staging of chronic lymphocytic leukemia", Blood 46, 219–234.
   PubMed Web of Science ®Google Scholar
• Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., Thomas, M., Tchernia, G., Jacquillat, C., Boivin, P., Lesty, C., Duault, MT., Monconduit, M., Belabbes, S. and Gremy, F. (1981) "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis", Cancer 48, 198–206.
   PubMed Web of Science ®Google Scholar
• Montserrat, E. (2002) "Classical and new prognostic factors in chronic lymphocytic leukemia: where to now?", Hematol. J. 3,7–9.
   PubMedGoogle Scholar
• Damle, RN., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, KR., Ferrarini, M. and Chiorazzi, N. (1999) "Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia", Blood 94, 1840–1847.
   PubMed Web of Science ®Google Scholar
• Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M. and Lichter, P. (2000) "Genomic aberrations and survival in chronic lymphocytic leukemia", N. Engl. J. Med. 343, 1910–1916.
   PubMed Web of Science ®Google Scholar
• Schroeder, H.W. Jr. and Dighiero, G. (1994) "The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire", Immunol. Today 15, 288–294, See comments.
   Google Scholar
• Hamblin, Ti., Davis, Z., Oscier, D.G. and Stevenson, F.K. (1999) "Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia", Blood 94, 1848–1854.
   PubMed Web of Science ®Google Scholar
• Maloum, K., Davi, F., Merle-Beral, H., Pritsch, 0., Magnac, C., Vuillier, F., Dighiero, G., Troussard, X., Mauro, F.F. and Benichou, J. (2000) "Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia", Blood 96, 377–379.
   PubMed Web of Science ®Google Scholar
• Khouri, IF., Keating, M., Korbling, M., Przepiorka, D., Anderlini, P., O'Brien, S., Giralt, S., Ippoliti, C., von Wolff, B., Gajewski, J., Donato, M., Claxton, D., Ueno, N., Andersson, B., Gee, A. and Champlin, R. (1998) "Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies", J. Clin. OncoL 16, 2817–2824.
   PubMed Web of Science ®Google Scholar
• Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., Pulendran, B. and Palucka, K. (2000) "Immunobiology of dendritic cells", Annu. Rev. Immunol. 18, 767–811.
   PubMed Web of Science ®Google Scholar
• Banchereau, J. and Steinman, R.M. (1998) "Dendritic cells and the control of immunity", Nature 392, 245–252.
   PubMed Web of Science ®Google Scholar
• Cella, M., Sallusto, F. and Lanzavecchia, A. (1997) "Origin, maturation and antigen presenting function of dendritic cells", Curr. Opin. Immunol. 9, 10–16.
   PubMed Web of Science ®Google Scholar
• Fong, L. and Engleman, E.G. (2000) "Dendritic cells in cancer immunotherapy", Annu. Rev. Immunol. 18, 245–273.
   PubMed Web of Science ®Google Scholar
• Lanzavecchia, A. (1996) "Mechanisms of antigen uptake for presentation", Curr. Opin. Immunol. 8, 348–354.
   PubMed Web of Science ®Google Scholar
• Sallusto, F., Cella, M., Daniell, C. and Lanzavecchia, A. (1995) "Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class 11 compartment: downregulation by cytokines and bacterial products", J. Exp. Med. 182, 389–400.
   PubMed Web of Science ®Google Scholar
• Chaux, P., Vantomme, V, Coulie, P., Boon, T. and van der Bruggen, P. (1998) "Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer", Int. J. Cancer 77, 538–542.
   PubMed Web of Science ®Google Scholar
• Fields, P., Fitch, F.W. and Gajewski, T.F. (1996) "Control of T lymphocyte signal transduction through clonal anergy", J. MoL Med. 74, 673–683.
   PubMed Web of Science ®Google Scholar
• Staveley-O'Carroll, K., Sotomayor, E., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D. and Levitsky, H. (1998) "Induction of antigen-specific T cell anergy: an early event in the course of tumor progression", Proc. Nati Acad. Sci. USA 95, 1178–1183.
   PubMed Web of Science ®Google Scholar
• Pulendran, B., Palucka, K. and Banchereau, J. (2001) "Sensing pathogens and tuning immune responses", Science 293, 253–256.
   PubMed Web of Science ®Google Scholar
• Jefford, M., Maraskovsky, E., Cebon, J. and Davis, ID. (2001) "The use of dendritic cells in cancer therapy", Lancet OncoL 2, 343–353.
   PubMedGoogle Scholar
• Caux, C., Vanbervliet, B., Massacrier, C., Dezutter-Dambuyant, C., de Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D. and Banchereau, J. (1996) "CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha", J. Exp. Med. 184, 695–706.
   PubMed Web of Science ®Google Scholar
• Sallusto, F. and Lanzavecchia, A. (1994) "Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha", J. Exp. Med. 179, 1109–1118.
   PubMed Web of Science ®Google Scholar
• Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P.O., Steinman, R.M. and Schuler, G. (1994) "Proliferating dendritic cell progenitors in human blood", J. Exp. Med. 180, 83–93.
   PubMed Web of Science ®Google Scholar
• Rezvany, MR., Jeddi-Tehrani, M., Biberfeld, P., Soderlund, J., Mellstedt, H., Osterborg, A. and Rabbani, H. (2001) "Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern", Br J. HaematoL 115, 263–271.
   PubMed Web of Science ®Google Scholar
• Vuillier, F., Maloum, K., Thomas, E.K., Jouanne, C., Dighiero, G. and Scott-Algara, D. (2001) "Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemia", Br J. HaematoL 115, 831–844.
   PubMed Web of Science ®Google Scholar
• Goddard, R.V., Prentice, A.G., Copplestone, J.A. and Kaminski, E.R. (2001) "Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cyto-toxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate", Clin. Exp. Immunol. 126, 16–28.
   PubMed Web of Science ®Google Scholar
• Krackhardt, A.M., Honig, S., Witzens, M., Broderick, R., Barrett, P. and Gribben, J.G. (2002) "T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy", Blood 100, 167–173.
   PubMed Web of Science ®Google Scholar
• Vuillier, E, Maloum, K., Thomas, E.K., Magnac, C., Dumas, G., Payelle-Brogard, B., Oppezzo, P., Dighiero, G. and Scott-Algara, D. (2003) "Idiotype-pulsed dendritic cells are able to induce anti-tumoral cytotoxic CD8 cells in chronic lymphocytic leukaemia", Br. J. Haematol. 120, 243–250.
   Web of Science ®Google Scholar
• Janeway, C.A., Jr, Sakato, N. and Eisen, H.N. (1975) "Recognition of immunoglobulin idiotypes by thymus-derived lymphocytes", Proc. Natl Acad. Sci. USA 72, 2357–2360.
   Google Scholar
• Bogen, B., Malissen, B. and Haas, W. (1986) "Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class 11 molecules", Eur. J. Immunol. 16, 1373–1378.
   PubMed Web of Science ®Google Scholar
• Campbell, M.J., Carroll, W., Kon, S., Thielemans, K., Rothbard, LB., Levy, S. and Levy, R. (1987) "Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits", J. Immunol. 139, 2825–2833.
   PubMed Web of Science ®Google Scholar
• George, A.J., Tutt, A.L. and Stevenson, F.K. (1987) "Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1", J. Immunol. 138, 628–634.
   PubMed Web of Science ®Google Scholar
• Bannerji, R. and Byrd, J.C. (2000) "Update on the biology of chronic lymphocytic leukemia", Curr. Opin. Oncol. 12, 22–29.
   PubMed Web of Science ®Google Scholar
• Buhmann, R., Nolte, A., Westhaus, D., Emmerich, B. and Hallek, M. (1999) "CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells", Blood 93, 1992–2002.
   PubMed Web of Science ®Google Scholar
• Rezvany, M.R., Jeddi-Tehrani, M., Rabbani, H., Lewin, N., Avila-Carino, J., Osterborg, A., Wigzell, H. and Mellstedt, H. (2000) "Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia", Br J. Haematol. 111, 608–617.
   PubMed Web of Science ®Google Scholar
• Trojan, A., Schultze, J.L., Witzens, M., Vonderheide, R.H., Ladetto, M., Donovan, J.W. and Gribben, J.G. (2000) "Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies", Nat. Med. 6, 667–672.
   PubMed Web of Science ®Google Scholar
• Honig, S., Witzens, M., Krackhardt, A.M., Trojan, A., Barrett, P., Broderick, R., Zauls, A.J. and Gribben, J.G. (2001) "Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues", Blood 98, 2999–3005.
   PubMed Web of Science ®Google Scholar
• Krackhardt, A.M., Witzens, M., Honig, S., Hodi, F.S., Zauls, A.J., Chessia, M., Barrett, P. and Gribben, J.G. (2002) "Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX", Blood 100, 2123–2131.
   PubMed Web of Science ®Google Scholar
• Reichardt, V.L., Okada, C.Y., Liso, A., Benike, C.J., Stockerl-Goldstein, K.E., Engleman, E.G., Blume, K.G. and Levy, R. (1999) "Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma—a feasibility study", Blood 93, 2411–2419.
   PubMed Web of Science ®Google Scholar
• Lim, S.H. and Bailey-Wood, R. (1999) "Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma", Int. J. Cancer 83, 215–222.
   PubMed Web of Science ®Google Scholar
• Titzer, S., Christensen, 0., Manzke, 0., Tesch, H., Wolf, J., Emmerich, B., Carsten, C., Diehl, V. and Bohlen, H. (2000) "Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects", Br. J. Haematol. 108, 805–816.
   PubMed Web of Science ®Google Scholar
• Hsu, FL, Benike, C., Fagnoni, F., Liles, T.M., Czerwinski, D., Taidi, B., Engleman, E.G. and Levy, R. (1996) "Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells", Nat. Med. 2, 52–58.
   PubMed Web of Science ®Google Scholar
• Steinman, R.M. and Pope, M. (2002) "Exploiting dendritic cells to improve vaccine efficacy", J. Clin. Investig. 109, 1519–1526.
   PubMed Web of Science ®Google Scholar
• Kelsall, B.L., Biron, C.A., Sharma, 0. and Kaye, P.M. (2002) "Dendritic cells at the host-pathogen interface", Nat. Immunol. 3, 699–702.
   Web of Science ®Google Scholar
• Pedersen, I.M., Kitada, S., Leoni, L.M., Zapata, J.M., Karras, J.G., Tsukada, N., Kipps, T.J., Choi, Y.S., Bennett, E and Reed, J.C. (2002) "Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mc1-1", Blood 100, 1795–1801.
   PubMed Web of Science ®Google Scholar
• Trentin, L., Cerutti, A., Zambello, R., Sancretta, R., Tassinari, C., Facco, M., Adami, E, Rodeghiero, E, Agostini, C. and Semenzato, G. (1996) "Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders", Blood 87, 3327–3335.
   PubMed Web of Science ®Google Scholar
• Jurlander, J., Lai, C.F., Tan, J., Chou, C.C., Geisler, C.H., Schriber, J., Blumenson, L.E., Narula, S.K., Baumann, H. and Caligiuri, M.A. (1997) "Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells", Blood 89, 4146–4152.
   PubMed Web of Science ®Google Scholar